APA (7th ed.) Citation

EP, J., DR, P., D, R., S, T., MC, R., S, A., & IF, P. (2022). Reversing tozasertib resistance in glioma through inhibition of pyruvate dehydrogenase kinases. Molecular oncology, 16(1), 219. https://doi.org/10.1002/1878-0261.13025

Chicago Style (17th ed.) Citation

EP, Jane, Premkumar DR, Rajasundaram D, Thambireddy S, Reslink MC, Agnihotri S, and Pollack IF. "Reversing Tozasertib Resistance in Glioma Through Inhibition of Pyruvate Dehydrogenase Kinases." Molecular Oncology 16, no. 1 (2022): 219. https://doi.org/10.1002/1878-0261.13025.

MLA (9th ed.) Citation

EP, Jane, et al. "Reversing Tozasertib Resistance in Glioma Through Inhibition of Pyruvate Dehydrogenase Kinases." Molecular Oncology, vol. 16, no. 1, 2022, p. 219, https://doi.org/10.1002/1878-0261.13025.